<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiovascular screening of athletes is a challenging aspect of the preparticipation evaluation </plain></SENT>
<SENT sid="1" pm="."><plain>While <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> in young athletes is uncommon, preparticipation screening may identify some predisposing conditions that place individuals at increased risk </plain></SENT>
<SENT sid="2" pm="."><plain>The most common pre-existing <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> in athletes causing <z:hpo ids='HP_0001699'>sudden death</z:hpo> in the United States are <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo>, congenital coronary anomalies, and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Preparticipation cardiovascular screening should pursue any history of cardiac symptoms or family history of premature <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e>, as well as abnormal cardiovascular physical findings </plain></SENT>
<SENT sid="4" pm="."><plain>Positive findings should be investigated; an electrocardiogram, echocardiogram, or consultation with a specialist should be considered </plain></SENT>
<SENT sid="5" pm="."><plain>Recommendations are then available to guide athletic participation according to the cardiovascular diagnosis </plain></SENT>
</text></document>